The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease

Perugino, CA; Alexander, T; Baker, MC; Brooks, D; Carruthers, MN; Chwalisz, BK; Chen, LYC; Culver, EL; Danforth, H; Della-Torre, E; Dong, L; Silva, GD; Ebbo, M; El-Saadany, H; Falaki, A; Freitag, S; Gray, ST; Hart, PA; Hedgire, SS; Hernandez-Barco, Y; Hernández-Molina, G; Hughes-Hallett, A; Inoue, D; Kambadakone, AR; Kamisawa, T; Karadag, O; Katz, G; Kawano, M; Keat, K; Kilian, A; Kleger, A; Lanzillotta, M; Löhr, JM; Lydston, M; Martin-Nares, E; Martinez-Valle, F; Masamune, A; Meysami, A; Murphy, P; Nakayamada, S; Okazaki, K; Park, WG; Provencher, A; Provencher, K; Rebours, V; Riddle, S; Saeki, T; Schleinitz, N; Sharma, A; Skelly, K; Tanaka, Y; Tomlinson, JAP; Travers, B; Tsuboi, H; Uchida, K; Umehara, H; Vaglio, A; Yamamoto, M; Yoshifuji, H; Zhang, W; Stone, JH; Khosroshahi, A

doi:10.1016/s2665-9913(26)00312-7

Autoinflammatory & rare systemic diseases

The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease

Lancet RheumatolPublished 9 Nov 2026guidelines

Read the original article ↗PubMed

Cite

Methodological detailssystematic literature search, evidence graded using the 2011 Oxford Centre for Evidence-Based Medicine Levels of Evidence framework, electronic consensus voting (more than 80% to agree or strongly agree)

Systematic literature search
Evidence graded using the 2011 Oxford Centre for Evidence-Based Medicine Levels of Evidence framework
Electronic consensus voting (more than 80% to agree or strongly agree)

Scope

As issued by the authors

treatment of IgG4-related disease

Reference

Issued by: IgG4ward! Foundation
Document: guidelines

Authors: Perugino CA, Alexander T, Baker MC, Brooks D, Carruthers MN, Chwalisz BK, et al.
All 62 authors
Perugino CA, Alexander T, Baker MC, Brooks D, Carruthers MN, Chwalisz BK, Chen LYC, Culver EL, Danforth H, Della-Torre E, Dong L, Silva GD, Ebbo M, El-Saadany H, Falaki A, Freitag S, Gray ST, Hart PA, Hedgire SS, Hernandez-Barco Y, Hernández-Molina G, Hughes-Hallett A, Inoue D, Kambadakone AR, Kamisawa T, Karadag O, Katz G, Kawano M, Keat K, Kilian A, Kleger A, Lanzillotta M, Löhr JM, Lydston M, Martin-Nares E, Martinez-Valle F, Masamune A, Meysami A, Murphy P, Nakayamada S, Okazaki K, Park WG, Provencher A, Provencher K, Rebours V, Riddle S, Saeki T, Schleinitz N, Sharma A, Skelly K, Tanaka Y, Tomlinson JAP, Travers B, Tsuboi H, Uchida K, Umehara H, Vaglio A, Yamamoto M, Yoshifuji H, Zhang W, Stone JH, Khosroshahi A
Journal: The Lancet Rheumatology
Published: 9 Nov 2026
DOI: 10.1016/s2665-9913(26)00312-7
PubMed: 43003101

Topic: Autoinflammatory & rare systemic diseases

Original publication

The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease. Lancet Rheumatol. Published 9 November 2026. doi:10.1016/s2665-9913(26)00312-7

Read the original article ↗

Composed by AI from the published abstract and checked against it. How Briefs are made →